1201644-33-8 Usage
Uses
Used in Organic Synthesis:
4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)morpholine is used as a building block in organic synthesis for the preparation of a variety of organic compounds. Its unique structure allows for versatile chemical reactions, making it a valuable component in creating new molecules with specific properties.
Used in Pharmaceutical Development:
In the pharmaceutical industry, 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)morpholine is used as a precursor in drug development and discovery. Its structural components can be manipulated to create potential drug candidates, offering new avenues for the treatment of various diseases and conditions.
Used in Materials Science:
4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)morpholine is also utilized in the field of materials science, particularly for the development of novel polymers and functional materials. Its incorporation into these materials can enhance their properties, such as stability, reactivity, or specific interactions with other molecules, making it a promising candidate for advanced material design.
Used in Research and Development:
In academic and industrial research settings, 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)morpholine serves as a subject of study for understanding its chemical properties and potential applications. Researchers explore its reactivity, stability, and interactions with other compounds to uncover new uses and optimize its synthesis for practical applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1201644-33-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,1,6,4 and 4 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1201644-33:
(9*1)+(8*2)+(7*0)+(6*1)+(5*6)+(4*4)+(3*4)+(2*3)+(1*3)=98
98 % 10 = 8
So 1201644-33-8 is a valid CAS Registry Number.
1201644-33-8Relevant academic research and scientific papers
NOVEL COMPOUNDS
-
, (2011/07/07)
The present invention relates to novel NADPH oxidase II inhibitors and their use in the treatment of diseases mediated by the NADPH oxidase II enzyme.
